However, the specific mechanism illustrating the involvement of TAZ in regulating the tumor-associated immunological processes lacks evidence, and the effects of prospective application of TAZ-related inhibitors on CRC immunotherapy remain to be further explored. This evidence concerns the gene WWTR1 and neoplasm.